Google Yahoo! Myspace YouTube Facebook Live eBay Wikipedia Craigslist Blogger Amazon Go CNN ESPN New York Times Weather About MapQuest Apple Ask Wal-Mart Chase Cnet Bank of America CareerBuilder
cancer
Doctors remove world's largest malignant tumour weighing FOUR STONE from woman, 54Gerard Couzens Daily Mail 08/26/2010 | WHO study has no clear answer on phones and cancerKate Kelland Reuters 05/16/2010 |
 Doctors have removed a tumour weighing nearly four stone from a woman in Argentina. It had been growing inside her body for 18 months. |  Experts who studied almost 13,000 cell phone users over 10 years, hoping to find out whether the mobile devices cause brain tumors, said on Sunday their research gave no clear answer. |
Study links sugary soft drinks to pancreas cancer Reuters 02/08/2010 | |
 A vaccine, containing agents boosting the body's response to skin cancer, is being tested in the UK. Early results show that the shot, which attacks tumour cells, but leaves healthy cells undamaged, has helped some patients fully recover from potentially fatal melanoma, even in its advanced stages. |  People who drink two or more sweetened soft drinks a week have a much higher risk of pancreatic cancer, an unusual but deadly cancer, researchers reported on Monday. |
Curry spice 'kills cancer cells' BBC News 10/29/2009 | Feds approve new cervical cancer vaccineSaundra Young CNN 10/16/2009 |
 An extract found in the bright yellow curry spice turmeric can kill off cancer cells, scientists have shown. |  WASHINGTON (CNN) -- The Food and Drug Administration approved a second vaccine intended to protect against cervical cancer. |
Mother can pass on cancer in womb BBC News 10/13/2009 | FDA Approves Pralatrexate for Treatment of Peripheral T-Cell Lymphoma SRI International 09/25/2009 |
 Scientists have proved that it is possible for a mother's cancer cells to be passed to her unborn child. |  The U.S. Food & Drug Administration has announced the approval of pralatrexate for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Research on drugs of this class began in the 1950s at SRI International. A subsequent scientific collaboration among SRI International, Memorial Sloan-Kettering Cancer Center, and Southern Research Institute led to clinical trials on related compounds conducted by Memorial Sloan-Kettering Cancer Center starting in the 1980s. Pralatrexate was identified as a viable clinical candidate and was licensed to Allos Therapeutics for further development in 2002. |
Virus linked to prostate tumours BBC News 09/08/2009 | Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine Scottsdale Healthcare 09/02/2009 |
 Scientists have produced compelling evidence that a virus known to cause cancer in animals is linked to prostate cancer in humans. |  A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients. |
New York, NY |
|
